<SEC-DOCUMENT>0001140361-19-003560.txt : 20190220
<SEC-HEADER>0001140361-19-003560.hdr.sgml : 20190220
<ACCEPTANCE-DATETIME>20190220171833
ACCESSION NUMBER:		0001140361-19-003560
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190219
FILED AS OF DATE:		20190220
DATE AS OF CHANGE:		20190220

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Backus William A.
		CENTRAL INDEX KEY:			0001530884

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13648
		FILM NUMBER:		19619387

	MAIL ADDRESS:	
		STREET 1:		52 SUNRISE PARK ROAD
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BALCHEM CORP
		CENTRAL INDEX KEY:			0000009326
		STANDARD INDUSTRIAL CLASSIFICATION:	CHEMICALS & ALLIED PRODUCTS [2800]
		IRS NUMBER:				132578432
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		P O BOX 600
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958
		BUSINESS PHONE:		8453265632

	MAIL ADDRESS:	
		STREET 1:		P O BOX 600
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2019-02-19</periodOfReport>

    <issuer>
        <issuerCik>0000009326</issuerCik>
        <issuerName>BALCHEM CORP</issuerName>
        <issuerTradingSymbol>BCPC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001530884</rptOwnerCik>
            <rptOwnerName>Backus William A.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BALCHEM CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>52 SUNRISE PARK ROAD</rptOwnerStreet2>
            <rptOwnerCity>NEW HAMPTON</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10958</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>true</isOfficer>
            <officerTitle>Chief Accounting Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2019-02-19</value>
            </transactionDate>
            <deemedExecutionDate>
                <value>2019-02-19</value>
            </deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>F</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>641</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>87.32</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>15927</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">On February 19, 2015, Balchem Corporation (the &quot;Company&quot;) granted 1,315 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Company and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement.  On February 19, 2019, 641 of the 1,315 shares that vested February 19, 2019 were withheld to cover withholding taxes due upon vesting.</footnote>
        <footnote id="F2">Beneficial Ownership reconciled to reflect this transaction and those reported on Form 4 filed on February 15, 2018.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ William A. Backus, by Attorney in Fact, Mark Stach</signatureName>
        <signatureDate>2019-02-20</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
